New Drugs2010, PART 1.
Hussar
Daniel A
DA
Pharmacy Philadelphia College of Pharmacy University of the Sciences, Philadelphia, PA, USA.
D000081:Acetamides / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins / Q000627:therapeutic use; D001381:Azepines / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D019905:Benzyl Alcohol / Q000627:therapeutic use; D001596:Benzylamines; D000080027:Cyclams; D003521:Cyclopropanes / Q000627:therapeutic use; D004338:Drug Combinations; D004358:Drug Therapy / Q000451:nursing* / Q000639:trends*; D064420:Drug-Related Side Effects and Adverse Reactions; D004983:Ethanolamines / Q000627:therapeutic use; D000068338:Everolimus; D000069465:Febuxostat; D005449:Fluorenes / Q000627:therapeutic use; D024841:Fluoroquinolones / Q000627:therapeutic use; D006074:Gout Suppressants / Q000627:therapeutic use; D006571:Heterocyclic Compounds / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use; D000078334:Lacosamide; D000078764:Milnacipran; D009842:Oligopeptides / Q000627:therapeutic use; D010636:Phenols / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D000077432:Tapentadol; D013844:Thiazoles / Q000627:therapeutic use; D000077602:Tolvaptan; D014230:Triazoles / Q000627:therapeutic use
D000081:Acetamides; D000911:Antibodies, Monoclonal; D000962:Antimalarials; D000077611:Artemether, Lumefantrine Drug Combination; D037621:Artemisinins; D001381:Azepines; D001552:Benzazepines; D001559:Benzhydryl Compounds; D019905:Benzyl Alcohol; D001596:Benzylamines; D000080027:Cyclams; D003521:Cyclopropanes; D004338:Drug Combinations; D004983:Ethanolamines; D000068338:Everolimus; D000069465:Febuxostat; D005449:Fluorenes; D024841:Fluoroquinolones; D006074:Gout Suppressants; D006571:Heterocyclic Compounds; D007166:Immunosuppressive Agents; D007211:Indoles; D000078334:Lacosamide; D000078764:Milnacipran; D009842:Oligopeptides; D010636:Phenols; D017367:Selective Serotonin Reuptake Inhibitors; D020123:Sirolimus; D000077432:Tapentadol; D013844:Thiazoles; D000077602:Tolvaptan; D014230:Triazoles; C431566:acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide; C526675:fesoterodine; C529000:golimumab; C522124:besifloxacin; C095285:silodosin; C088327:plerixafor; C079703:rufinamide